In this regulation, “novel product” means a cannabis product that is: Not presently authorized in Maryland; and Lawfully produced in another jurisdiction. A licensed processor may submit a request to the Administration in a manner prescribed by the Administration to approve a novel product. A valid novel product request shall include: A detailed product description; An explanation of how the product deviates from current regulations; Evidence that the same product type is permitted in at least one other state’s regulated cannabis market; and Health and safety information, including but not limited to: Available information or studies regarding any beneficial or adverse effects from the use of the product; and Packaging and labeling strategies to minimize risk to patients, consumers, and children. The Administration may: Make its own determination to approve or deny the request; or Defer the request to the Public Health Advisory Council. The Administration reserves the right to make a final determination on the request